Knowledge

Across topics and issues, borders and industries, we have the thought leadership you need to stay ahead of changes in the law.

Follow us:

Publications

News

Italy further strengthens its "golden powers" on FDI, 5G and cloud tech due to the Ukrainian crisis

On March 21st, 2022, the Italian Government adopted Law Decree No. 21/2022 introducing urgent measures to react to the economic and humanitarian effects of the Ukrainian crisis...

Insights

Insurance M&A Trends in Europe
Registered Content

Contrary to expectations, 2020 was globally one of the most active years for insurance M&A since the financial crisis. Over US$93 billion in M&A deals were signed with the largest...

News

Getting The Deal Through: Automotive 2021
Registered Content

For the fifth time, we have collaborated with Lexology to publish Getting the Deal Through: Automotive, our market overview of key issues in the automotive industry covering 19 countries....

News

New Release: Insurance Horizons Brochure 2021

We are pleased to announce the release of this year's Insurance Horizons Brochure!

Analysis

Government extends "golden powers" on FDI during the COVID-19 emergency COVID-19 newsflash

On 8 April 2020, the Italian government adopted the wide-ranging Law Decree No. 23 (Urgent Measures Law), which also amends the government's so-called "golden powers" of intervention in...

Hogan Lovells Publications

A road map to successful life sciences transactions in Europe

U.S. based life sciences companies considering transactions in Europe may easily become overwhelmed with the complexity of Europe’s various jurisdictions.

Hogan Lovells Publications

Italy inbound: look no further

Hogan Lovells Publications

Italy improves transparency and extends its "golden powers" to protect new (corporate) treasures

On October 16, 2017 the Italian government adopted Law Decree no. 148/2017 (the "Decree") containing, inter alia, new measures aimed at improving the transparency of Italy's regulated...

Hogan Lovells Publications

A road map to life sciences M&A in Italy

U.S.-based life sciences companies considering transactions in Europe may easily become overwhelmed with the complexity of Europe’s various jurisdictions. In this series, members of...

Loading data